Miacalcic combined with XLGB efficacy of the treatment of osteoporosis.doc

Miacalcic combined with XLGB efficacy of the treatment of osteoporosis.doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Miacalcic combined with XLGB efficacy of the treatment of osteoporosis

 PAGE \* MERGEFORMAT 9 Miacalcic combined with XLGB efficacy of the treatment of osteoporosis Osteoporosis is a decrease in bone mass, bone micro-structural damage leading to reduced bone strength, bone fragility is characterized by systemic skeletal system degenerative disease, main clinical manifestations were bone pain and fractures, a serious threat to the elderly health. With the global population ages, the prevalence of osteoporosis will continue to increase, to society, a heavy burden on the family, so are more and more attention. In recent years, we have adopted a joint Miacalcic Xianlinggubao capsule in treating osteoporosis, a significant effect, are reported below. Clinical data to write a thesis 1.1 General information on 84 cases of osteoporosis in elderly patients were Fujian Medical College Second People’s Hospital in February 2004 ~ November 2006 admitted to the inpatient and outpatient cases. Treatment group, 43 cases were males and 14 cases, female 29, age 52 to 84 years, an average of 62.5 years, duration 2 ~ 13 a, an average of 7 a. 41 patients in the control group, male 10 cases, female 31 cases, aged 49 to 85 years old, group treatment and control groups in Table 12 groups of clinical main symptoms low back pain to improve the situation (%) n4341 markedly 32 (74.4) 6 (14.6) Effective 10 (23.3) 12 (29.3) Invalid 1 (2.3) 23 (56.1) Total effective rate 42 (97.7) 118 (43.9) Note: compared with the control group, 1) P amp;lt;0.05 Table 2 Determination results of BMD before and after treatment (x ± s) part of the waist of the greater trochanter before treatment 0.835 ± 0.2220.681 ± 0.121 after treatment 0.947 ± 0.2631) 0.687 ± 0.411 Note: before treatment, 1) P amp;lt;0.05 pre-treatment 0.833 ± 0.1520.632 ± 0.112 after treatment 0.857 ± 0.1130 .637 ± 0.203 treatment group (n = 43) control group (n = 41) average 60.4 years, duration of 2 ~ 15 a, an average of 8 a. Patients also meet the following conditions: all the objects of liver a

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档